Staphylococcus aureus and topical fusidic acid use: results of a clinical audit on antimicrobial resistance

International Journal of Dermatology, 02/27/2013

Several studies have linked trends in prescribing medication and topical use of fusidic acid (FA) to development of resistance. However, few case–control studies have evaluated risk factors for developing FA resistance in S. aureus. Previous recent topical FA use correlated positively with FA resistance in S. aureus. Prescribing physicians must be vigilant of the rise of FA resistance and its resultant problems and prescribe topical FA discerningly.

Print Article Summary Cat 2 CME Report